vers la météo de la validation par utilisateur

Ingenuity407


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 78 - PMID ?

Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 1
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 2
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 3
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 4
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 5
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 6
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 7
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 8
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 9
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 10
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 11
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 12
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 13
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 14
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 15
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 16
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 17
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 18
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 19
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 20
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 21
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 22
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 23
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 24
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 25
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 26
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 27
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 28
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 29
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 30
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 31
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 32
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 33
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 34
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 35
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 36
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 37
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 38
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 39
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 40
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 41
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 42
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 43
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 44
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 45
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 46
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 47
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 48
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 49
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 50
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 51
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 52
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 53
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 54
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 55
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 56
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 57
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 58
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 59
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 60
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 61
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 62
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 63
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 64
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 65
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 66
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 67
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 68
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 69
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 70
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 71
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 72
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 73
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 74
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 75
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 76
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 77
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 78
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 79
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 80
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 81
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 82
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 83
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 84
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 85
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 86
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 87
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 88
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 89
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 90
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 91
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 92
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 93
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 94
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 95
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 96
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 97
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 98
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 99
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 100
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 101
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 102
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 103
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 104
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 105
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 106
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 107
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 108
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 109
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 110
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 111
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 112
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 113
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 114
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 115
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 116
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 117
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 118
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 119
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 120
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 121
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 122
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 123
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 124
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 125
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 126
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 127
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 128
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 129
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 130
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 131
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 132
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 133
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 134
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 135
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 136
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 137
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 138
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 139
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 140
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 141
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 142
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 143
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            +-----------------COMP:V-N(in)-----------------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 144
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 145
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 146
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 147
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 148
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 149
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 150
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 151
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 152
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 153
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 154
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 155
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 156
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 157
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 158
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 159
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                                         +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+                 +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |                 |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 160
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 161
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 162
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 163
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 164
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 165
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 166
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 167
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 168
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 169
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 170
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 171
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 172
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 173
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 174
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 175
                                                                            +----------------------COMP:V-N(from)----------------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 176
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 177
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 178
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 179
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 180
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 181
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 182
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 183
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 184
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 185
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 186
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 187
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +-----------------COMP:V-N(in)-----------------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,muscle)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 188
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 189
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 190
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 191
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            +----------------------COMP:V-N(from)----------------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(from) (increase,__SP__)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 192
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 193
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 194
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 195
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 196
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 197
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 198
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 199
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 200
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 201
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 202
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 203
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 204
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 205
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 206
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 207
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 208
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 209
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 210
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 211
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 212
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 213
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 214
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 215
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 216
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 217
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 218
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 219
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 220
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 221
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 222
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 223
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 224
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 225
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 226
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 227
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 228
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                                                                                    |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 229
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 230
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 231
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 232
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 233
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 234
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 235
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 236
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 237
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 238
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 239
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 240
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 241
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 242
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 243
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 244
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 245
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 246
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 247
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 248
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 249
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 250
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 251
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 252
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 253
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 254
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 255
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 256
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 257
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 258
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 259
                                                                                                                                                    +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 260
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 261
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 262
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 263
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 264
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 265
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +------------COMP:N-N(in)-----------+                                               +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        +--------SUBJ:V-N--------+       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,muscle)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 266
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 267
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 268
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 269
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 270
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 271
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 272
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 273
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 274
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 275
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 276
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |                                                                                              +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 277
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +-----------------COMP:N-N(from)----------------+                                                                                            |    
                                                                            |          +------------COMP:N-N(in)-----------+           |                                   +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           +--SUBJ:V-N--+       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,__SP__)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 278
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 279
                                                                                       +--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 280
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 281
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 282
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 283
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 284
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 285
                                                                                       +--------------------------SUBJ:V-N--------------------------+                                                                                    
                                                                                       +-----------------COMP:N-N(from)----------------+            +----------------------------------COMP:V-N(in)---------------------------------+    
                                                                                       +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
COMP:V-N(in) (involve,__SP__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 286
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 287
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                                 |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 288
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 289
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 290
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 291
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                                 +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
COMP:N-N(from) (mRNA,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 292
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 293
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 294
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 295
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+                        |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |                        +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |                        |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        +COMP:N-N(fr+            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (muscle,__SP__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 296
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 297
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 298
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 299
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+                    |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+                    |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+COMP:N-N+           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,muscle)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 300
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 301
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 302
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)

Analyse 303
                                                                            +----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+    
                                                                            |          +--------------------------SUBJ:V-N--------------------------+                                                                               |    
                                                                            |          +-----------------COMP:N-N(from)----------------+            |                                                                               |    
                                                                            |          +------------COMP:N-N(in)-----------+           |            |                      +-------------------APPOS-------------------+            |    
             +---------------------------SUBJ:V-N---------------------------+          +-------COMP:N-N(of)-------+        |           |            +--------OBJ:V-N-------+                +-------MOD_ATT:N-ADJ------+            |    
             |                       +-----------OBJ:V-N----------+         |          |           +-MOD_ATT:N-ADJ+        |           |            |       +-MOD_ATT:N-ADJ+                |           +-MOD_ATT:N-ADJ+            |    
   +MOD_ATT:N+-COMP:N-N(of)-+        |        +MOD_ATT:+COMP:N+   |         +--OBJ:V-N-+           |       +MOD_AT+        |           |            |       |      +MOD_ATT+                |           |       +MOD_AT+            |    
   |         |              |        |        |        |      |   |         |          |           |       |      |        |           |            |       |      |       |                |           |       |      |            |    
 Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ .
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,2)
SUBJ:V-N (increase,administration)
OBJ:V-N (increase,expression)
COMP:V-N(in) (increase,__SP__)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,muscle)
COMP:N-N(from) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,__NODE__)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,mutation)
MOD_ATT:N-ADJ (mutation,unspecified)
MOD_ATT:N-ADJ (mutation,homozygous)
MOD_ATT:N-N (mutation,gene)